HERTFORDSHIRE, England and
PITTSBURGH, May 4, 2016 /PRNewswire/ -- In an effort to
drive a national movement about the serious and unpredictable
nature of anaphylaxis, a life-threatening allergic reaction, Mylan
N.V. (NASDAQ, TASE: MYL), a leading global pharmaceutical company,
is today unveiling an initiative called Anaphylaxis: For
Reel™. Through this initiative Mylan, along with actor,
producer, businesswoman and mother, Sarah
Jessica Parker, and leading advocacy organizations, aims to
inspire greater understanding about the risks of anaphylaxis.
Anaphylaxis: For Reel™ encourages young filmmakers and their
families to make their voices heard by creating and submitting
short, educational films about the realities of managing severe
allergies. Parker, whose son has allergies to peanuts and
hazelnuts, is joining this initiative to share her story and
personal connection to this life-threatening health condition that
affects families nationwide.
To visit the multimedia assets associated with this release,
please click:
http://www.multivu.com/players/English/7796131-mylan-anaphylaxis-for-reel/
"With Anaphylaxis: For Reel™, I hope to help
empower other families affected by severe allergies to share their
personal stories," Parker said. "Like every family, we have our own
story. We learned about our son's food allergies only after he
experienced anaphylaxis – and I still vividly remember how scary
that day was for all of us. Since then, we've come to understand
just how serious the risks of anaphylaxis are – and how crucial it
is to take proactive steps to manage his severe allergies."
Anaphylaxis is a significant health issue in the U.S., with up
to 43 million people at risk, including children affected by food
allergies, estimated at one in 13. Every six minutes, on average,
food-related anaphylaxis sends someone in the U.S. to the emergency
department. While avoidance of allergic triggers is the critical
first step in managing severe allergies, accidental exposure can
happen at any time, making it important to have an anaphylaxis
action plan. This includes knowing the signs and symptoms of
anaphylaxis, always having access to two epinephrine auto-injectors
and knowing when to use them and seeking immediate medical care
after use. Epinephrine is the only first-line treatment for
anaphylaxis, and delayed administration is the single highest
predictor of the rare occurrence of death. Antihistamines do not
treat or relieve the life-threatening symptoms of anaphylaxis.
"Anaphylaxis is very unpredictable – symptoms can vary from
person to person, and reactions can be mild one time and
life-threatening the next," said Dr. Hemant
Sharma, Clinical Chief of the Division of Allergy and
Immunology at Children's National Health System in Washington D.C. "Our goal with this initiative
is to have the real-life, everyday stories of those who deal with
life-threatening allergies firsthand shine a spotlight on the
urgent need to increase education about the importance of being
ready to respond if anaphylaxis occurs."
A panel, including Dr. Hemant
Sharma and leading advocacy organization members, will come
together to select up to five films to be featured at a premiere
event in New York City this fall
with Parker and posted on Anaphylaxis101.com. Films can be
submitted on Anaphylaxis101.com through July
11. Films will be evaluated based upon creativity,
originality and adherence to submission guidelines.
The advocacy groups involved with the
initiative include:
- Allergy & Asthma Network (AAN)
- American Latex Allergy Association (ALAA)
- Asthma and Allergy Foundation of America (AAFA)
- Food Allergy & Anaphylaxis Connection Team (FAACT)
- Food Allergy Research & Education (FARE)
- Kids with Food Allergies (KFA)
For more information about Anaphylaxis: For Reel™ and for
complete rules, terms and conditions, visit Anaphylaxis101.com.
Sarah Jessica Parker and Dr.
Hemant Sharma are paid spokespeople
of Mylan.
About Anaphylaxis
Anaphylaxis is a life-threatening
allergic reaction that has many possible triggers, occurs quickly,
without warning, and must be treated immediately with
epinephrine. Symptoms may include hives, itching, swelling or
redness of the skin, tightness in the throat, nausea, dizziness,
breathing problems, a decrease in blood pressure and/or fainting.
Anaphylaxis can be caused by triggers, such as food, stinging and
biting insects, medicines, latex or even exercise. While symptoms
of an allergic reaction vary from person to person, reactions can
quickly progress to become life-threatening.
About Mylan
Mylan is a global pharmaceutical company
committed to setting new standards in healthcare. Working together
around the world to provide 7 billion people access to high quality
medicine, we innovate to satisfy unmet needs; make reliability and
service excellence a habit; do what's right, not what's easy; and
impact the future through passionate global leadership. We offer a
growing portfolio of more than 1,400 generic and branded
pharmaceuticals, including antiretroviral therapies on which
approximately 50% of people being treated for HIV/AIDS in the
developing world depend. We market our products in approximately
165 countries and territories. Our global R&D and manufacturing
platform includes more than 50 facilities, and we are one of the
world's largest producers of active pharmaceutical ingredients.
Every member of our nearly 35,000-strong workforce is dedicated to
creating better health for a better world, one person at a time.
Learn more at mylan.com.
Anaphylaxis: For Reel™ is a trademark owned by the Mylan
companies. The Mylan logo is a registered trademark of Mylan
Inc.
© 2016 Mylan Specialty L.P. All rights reserved.
NON-2016-0256
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sarah-jessica-parker-shares-her-personal-experience-with-potentially-life-threatening-severe-allergies-through-mylans-anaphylaxis-for-reel-initiative-300262660.html
SOURCE Mylan N.V.